Which leukocyte subsets predict cardiovascular mortality? From the LUdwigshafen RIsk and Cardiovascular Health (LURIC) Study

Atherosclerosis

Volumn 224, Issue 1, 2012, Pages 161-169

  ó Hartaigh, Bríain ^a   Bosch, Jos A ^a,b,c   Thomas, G Neil ^a,c   Lord, Janet M ^a   Pilz, Stefan ^c,d   Loerbroks, Adrian ^c   Kleber, Marcus E ^c   Grammer, Tanja B ^c   Fischer, Joachim E ^c   Boehm, Bernhard O ^e   März, Winfried ^c,d,f  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e UNIVERSITY OF ULM   (Germany)

^f SYNLAB ACADEMY   (Germany)

Author keywords

C reactive protein; Cardiovascular disease; Neutrophil; White blood cell

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INFECTION; LEUKOCYTE; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NEUTROPHIL COUNT; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; FEMALE; GERMANY; HUMANS; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; LYMPHOCYTES; MALE; MIDDLE AGED; MONOCYTES; NEUTROPHILS; PROSPECTIVE STUDIES;

EID: 84865372395     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.04.012     Document Type: Article

References (46)

1. Friedman G.D., Klatsky A.L., Siegelaub A.B. The leukocyte count as a predictor of myocardial infarction. N Engl J Med 1974, 290:1275-1278.
2. Ernst E., Hammerschmidt D.E., Bagge U., et al. Leukocytes and the risk of ischemic diseases. JAMA 1987, 257:2318-2324.
3. Hansen L.K., Grimm R.H., Neaton J.D. The relationship of white blood cell count to other cardiovascular risk factors. Int J Epidemiol 1990, 19:881-888.
4. Weber C., Zernecke A., Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol 2008, 8:802-815.
5. Madjid M., Awan I., Willerson J.T., et al. Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol 2004, 44:1945-1956.
6. Dragu R., Huri S., Zuckerman R., et al. Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction. Atherosclerosis 2008, 196:405-412.
7. Horne B.D., Anderson J.L., John J.M., et al. Which white blood cell subtypes predict increased cardiovascular risk?. J Am Coll Cardiol 2005, 45:1638-1643.
8. Duffy B.K., Gurm H.S., Rajagopal V., et al. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol 2006, 97:993-996.
9. Nunez J., Nunez E., Bodi V., et al. Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol 2008, 101:747-752.
10. Zhou X., Nicoletti A., Elhage R., et al. Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 2000, 102:2919-2922.
11. Hansson G.K. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 2001, 21:1876-1890.
12. Galkina E., Ley K. Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol 2009, 27:165-197.
13. Danesh J., Collins R., Appleby P., et al. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. Jama 1998, 279:1477-1482.
14. Winkelmann B.R., Marz W., Boehm B.O., et al. Rationale and design of the LURIC study - a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics 2001, 2:S1-73.
15. Curnow S.J., Fairclough M., Schmutz C., et al. Distinct types of fibrocyte can differentiate from mononuclear cells in the presence and absence of serum. PLoS One 2010, 5:e9730.
16. Turner J.E., Bosch J.A., Drayson M.T., et al. Assessment of oxidative stress in lymphocytes with exercise. J Appl Physiol 2011, 111:206-211.
17. Anane L.H., Edwards K.M., Burns V.E., et al. Phenotypic characterization of gammadelta T cells mobilized in response to acute psychological stress. Brain Behav Immun 2010, 24:608-614.
18. Saikku P., Leinonen M., Mattila K., et al. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988, 2:983-986.
19. Guech-Ongey M., Brenner H., Twardella D., et al. Role of cytomegalovirus sero-status in the development of secondary cardiovascular events in patients with coronary heart disease under special consideration of diabetes. Int J Cardiol 2006, 111:98-103.
20. Hsich E., Zhou Y.F., Paigen B., et al. Cytomegalovirus infection increases development of atherosclerosis in apolipoprotein-E knockout mice. Atherosclerosis 2001, 156:23-28.
21. Jason P.F., Gray R.J. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999, 94:496-509.
22. Pencina M.J., D'Agostino R.B., D'Agostino R.B., et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008, 27:157-172. [discussion 207-12].
23. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001, 285:2486-2497.
24. Danesh J., Wheeler J.G., Hirschfield G.M., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004, 350:1387-1397.
25. Tall A.R. C-reactive protein reassessed. N Engl J Med 2004, 350:1450-1452.
26. Dehghan A., Dupuis J., Barbalic M., et al. Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation 2011, 123:731-738.
27. Elliott P., Chambers J.C., Zhang W., et al. Genetic loci associated with C-reactive protein levels and risk of coronary heart disease. Jama 2009, 302:37-48.
28. Haumer M., Amighi J., Exner M., et al. Association of neutrophils and future cardiovascular events in patients with peripheral artery disease. J Vasc Surg 2005, 41:610-617.
29. Sweetnam P.M., Thomas H.F., Yarnell J.W., et al. Total and differential leukocyte counts as predictors of ischemic heart disease: the Caerphilly and Speedwell studies. Am J Epidemiol 1997, 145:416-421.
30. Grau A.J., Boddy A.W., Dukovic D.A., et al. Leukocyte count as an independent predictor of recurrent ischemic events. Stroke 2004, 35:1147-1152.
31. Prentice R.L., Szatrowski T.P., Fujikura T., et al. Leukocyte counts and coronary heart disease in a Japanese cohort. Am J Epidemiol 1982, 116:496-509.
32. Huang Z.S., Chien K.L., Yang C.Y., et al. Peripheral differential leukocyte counts and subsequent mortality from all diseases, cancers, and cardiovascular diseases in Taiwanese. J Formos Med Assoc 2003, 102:775-781.
33. Kawaguchi H., Mori T., Kawano T., et al. Band neutrophil count and the presence and severity of coronary atherosclerosis. Am Heart J 1996, 132:9-12.
34. Zernecke A., Bot I., Djalali-Talab Y., et al. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ Res 2008, 102:209-217.
35. Sainz J., Sata M. Open sesame! CXCR4 blockade recruits neutrophils into the plaque. Circ Res 2008, 102:154-156.
36. Moreno J.A., Ortega-Gomez A., Delbosc S., et al. In vitro and in vivo evidence for the role of elastase shedding of CD163 in human atherothrombosis. Eur Heart J 2012, 33:252-263.
37. van Leeuwen M., Gijbels M.J., Duijvestijn A., et al. Accumulation of myeloperoxidase-positive neutrophils in atherosclerotic lesions in LDLR-/- mice. Arterioscler Thromb Vasc Biol 2008, 28:84-89.
38. Shoenfeld Y., Pinkhas J. Leukopenia and low incidence of myocardial infarction. N Engl J Med 1981, 304:1606.
39. Siminiak T., Flores N.A., Sheridan D.J. Neutrophil interactions with endothelium and platelets: possible role in the development of cardiovascular injury. Eur Heart J 1995, 16:160-170.
40. Siminiak T., Ozawa T. Neutrophil mediated myocardial injury. Int J Biochem 1993, 25:147-156.
41. 2O reveals a human neutrophil lifespan of 5.4 days. Blood 2010, 116:625-627.
42. Silva M.T. Macrophage phagocytosis of neutrophils at inflammatory/infectious foci: a cooperative mechanism in the control of infection and infectious inflammation. J Leukoc Biol 2011, 89:675-683.
43. Jitkaew S., Witasp E., Zhang S., et al. Induction of caspase- and reactive oxygen species-independent phosphatidylserine externalization in primary human neutrophils: role in macrophage recognition and engulfment. J Leukoc Biol 2009, 85:427-437.
44. Stowell S.R., Qian Y., Karmakar S., et al. Differential roles of galectin-1 and galectin-3 in regulating leukocyte viability and cytokine secretion. J Immunol 2008, 180:3091-3102.
45. Imanishi T., Ikejima H., Tsujioka H., et al. Association of monocyte subset counts with coronary fibrous cap thickness in patients with unstable angina pectoris. Atherosclerosis 2010, 212:628-635.
46. Rogacev K.S., Ulrich C., Blomer L., et al. Monocyte heterogeneity in obesity and subclinical atherosclerosis. Eur Heart J 2010, 31:369-376.